Rizatriptan Benzoate

Common brands: Maxalt, Maxalt-Mlt, Topamax, Neurontin, Pain Relief

Top reporter: Organon Llc

Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]Provitamin D2 Compound [EPC]
9,966
Total Reports
2,921
Serious Reports
192
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.93%)

Patient Demographics

Male
1,306
Female
7,906

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Rizatriptan Benzoate.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 1,454
9.7%
2 NAUSEA 1,154
7.7%
3 HEADACHE 1,017
6.8%
4 MIGRAINE 977
6.5%
5 OFF LABEL USE 851
5.7%
6 FATIGUE 654
4.4%
7 PAIN 607
4.0%
8 PRODUCT USE IN UNAPPROVED INDICATION 544
3.6%
9 HYPERHIDROSIS 518
3.4%
10 VOMITING 461
3.1%
11 DIARRHOEA 439
2.9%
12 DIZZINESS 426
2.8%
13 DYSPNOEA 417
2.8%
14 SEDATION 416
2.8%
15 NIGHTMARE 414
2.8%
16 ANXIETY 393
2.6%
17 NEPHROLITHIASIS 381
2.5%
18 HYPERSENSITIVITY 359
2.4%
19 ARTHRALGIA 350
2.3%
20 DEPRESSION 338
2.3%
21 INSOMNIA 332
2.2%
22 MALAISE 321
2.1%
23 DRUG INTOLERANCE 290
1.9%
24 FEELING ABNORMAL 288
1.9%
25 ABDOMINAL PAIN 277
1.8%
26 COUGH 275
1.8%
27 FALL 275
1.8%
28 WEIGHT DECREASED 275
1.8%
29 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 259
1.7%
30 SINUSITIS 257
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.